Skip to main content
TipRanks
Go Ultimate75% OFF

Spago Nanomedical AB (7UX) Revenue

1 Followers

Spago Nanomedical AB Revenue

Spago Nanomedical AB had a revenue of 0.00 in the quarter ending Jun 30, 2026, with -100.00%. This bring the company's revenue in the last twelve months to 40.00K, Decreased 66.94%. In the fiscal year ending Dec 31, 2025, Spago Nanomedical AB had annual revenue of 437.00K with -77.13% growth.

Revenue (ttm)
40.00K
Revenue Growth
-97.38%
P/S Ratio
7.24
Revenue/Employee
EUR 72,833
Employees
6
Market Cap
EUR 3.16M

Revenue Chart

Spago Nanomedical AB Revenue - Annual

05M10M15M20M25M30M35M47.00K29.64M30.00K342.00K660.00K1.05M1.20M1.91M437.00K201720182019202020212022202320242025
Revenue History
Download to Excel
DE:7UX revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025437.00K-1.47M-77.13%
Dec 31, 20241.91M708.00K58.85%
Dec 31, 20231.20M149.00K14.14%
Dec 31, 20221.05M394.00K59.70%
Dec 31, 2021660.00K318.00K92.98%
Dec 31, 2020342.00K312.00K1040.00%
Dec 31, 201930.00K-29.61M-99.90%
Dec 31, 201829.64M29.60M62972.34%
Dec 31, 201747.00K――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DE:7UX40.00K
SE:BIOVIC.B14.83M
SE:XSPRAY0.00
SE:IMMU0.00
SE:CANTA317.31M
SE:FLUO54.00K